OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Publication Date
Release Date
2015
(3)
2023
(2)
2022
(2)
2024
(1)
2021
(1)
2019
(1)
2016
(1)
2009
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial.
Not available
S-EPMC6888890
|
biostudies-literature
Cite
Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.
Not available
S-EPMC2695662
|
biostudies-literature
Cite
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes: A FIDELITY Subgroup Analysis.
Not available
S-EPMC10278789
|
biostudies-literature
Cite
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
Not available
S-EPMC10214179
|
biostudies-literature
Cite
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS.
Not available
S-EPMC5200636
|
biostudies-literature
Cite
Identification of six new susceptibility loci for invasive epithelial ovarian cancer.
Not available
S-EPMC4445140
|
biostudies-literature
Cite
Characterizing Long COVID in Children and Adolescents.
Not available
S-EPMC11339705
|
biostudies-literature
Cite
Ertugliflozin and Slope of Chronic eGFR: Prespecified Analyses from the Randomized VERTIS CV Trial.
Not available
S-EPMC8729577
|
biostudies-literature
Cite
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study.
Not available
S-EPMC9271031
|
biostudies-literature
Cite
Genetic studies of body mass index yield new insights for obesity biology.
Not available
S-EPMC4382211
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets